Unexpected effect of probiotics by Lactococcus lactis subsp. lactis against colitis induced by dextran sulfate sodium in mice

• Published in: Journal of Infection and Chemotherapy Vol. 26; no. 6; pp. 549 - 553
• Main Authors: Komaki, Shinichirou, Haque, Anwarul, Miyazaki, Haruko, Matsumoto, Tetsuya, Nakamura, Shigeki
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.06.2020; Elsevier BV
• Subjects: Animals; Colitis, Ulcerative; Colitis, Ulcerative - chemically induced; Colitis, Ulcerative - microbiology; Colitis, Ulcerative - pathology; Colon; Colon - immunology; Colon - pathology; Cytokines; Cytokines - blood; Dextran Sulfate; Dextran sulfate sodium-induced colitis; Disease Models, Animal; Female; Lactococcus lactis; Mice; Mice, Inbred C57BL; Probiotics; Probiotics - administration & dosage; Probiotics - adverse effects; Survival Analysis; Lactococcus lactis; Probiotics; Dextran sulfate sodium-induced colitis
• ISSN: 1341-321X; 1437-7780; 1437-7780
• DOI: 10.1016/j.jiac.2020.01.006

Ulcerative colitis (UC) is a representative intestinal chronic inflammatory disease whose incidence is rapidly increasing worldwide. It was previously shown that some specific probiotics help to guard against UC. In this study, we analyzed the effect of Lactococcus lactis subsp. lactis JCM5805 (L. lactis), which has been put to practical use as a probiotic, on the pathogenesis of UC using a dextran sulfate sodium-induced colitis mouse model. Survival rate, length, and histopathological parameters of the colon were elucidated. Further, the concentrations of inflammatory cytokines in serum were measured. As a result, the oral administration of high-dose L. lactis showed significant decreases in survival rate and colon length. Histopathological analysis showed that a bleeding appearance was observed in the L. lactis group, and the histology scores in the L. lactis group were significantly higher than those in the normal saline group. Furthermore, the levels of interferon gamma, tumor necrosis factor alpha, and interleukin-6 were significantly elevated in the L. lactis group. These results support that high-dose administration of L. lactis deteriorates intestinal inflammation and suggest that the careful selection of probiotics strains and administration dose is important for improving colitis including UC.